General Information

Lipoic Acid Mineral Complex (LAMC), also known in North America as ‘PolyMVA,’ is classified by the FDA as a nutritional supplement. However, in veterinary medicine, LAMC is used as a drug, and a similar formulation was once available as a human drug. LAMC is sometimes confused with alpha lipoic acid (ALA), as it contains ALA, but it is distinct and has more peer-reviewed research.

Scientific studies show that LAMC can rebuild mitochondrial numbers and density, improve neuro-inflammatory markers and function, offer protection from radiation, and aid recovery from radiation injury. Additionally, it demonstrates potential anti-cancer properties. LAMC acts as a ‘Re-Dox molecule,’ meaning it quickly enters the cell and then the mitochondria, where its primary activity takes place. It has shown benefits in patients with multiple sclerosis, hematologic cancers, and mitochondrial injuries, among others, especially when administered via IV drip therapy.

Safety and the Palladium Issue

There are some concerns about the presence of palladium (Pd) in LAMC. However, the Pd is not in free form; it is bound to the residues of two ALA molecules, forming a non-reducing bond. This means the Pd is ‘locked’ in the molecule, similar to how iron is bound in hemoglobin. Clinical trials in humans and animals have shown no toxicity, making LAMC a safe option for intravenous use in IV infusion drip therapies.

Clinical Use and Benefits

Over the past seven years, LAMC has been used in clinical settings to treat patients with cancer as well as non-cancer chronic illnesses. In cancer care, LAMC has shown promising results, as outlined in the ’11 DCA and LAMC – Poly MVA Anderson Protocol.’ However, LAMC has also proven effective for non-cancer applications, including fatiguing illnesses like fibromyalgia syndrome (FMS), chronic fatigue syndrome (CFS), post-infectious syndromes, and neuro-inflammatory disorders like multiple sclerosis (MS) and Parkinson’s disease.

For best results, LAMC can be administered through both IV drip and oral routes. Typically, an IV loading dose strategy followed by oral dosing leads to faster progress in patients.

General Administration Ideas

Patients with fatiguing illnesses or neuro-inflammatory disorders tend to need a lower initial dose, with a slower ramp-up to the full dose. This strategy helps avoid potential side effects and ensures better tolerance to the treatment.

Conclusion

Lipoic Acid Mineral Complex (LAMC) offers a versatile and effective treatment option for a variety of chronic conditions, including cancer, fatigue, and neuro-inflammatory disorders. When administered via IV drips, LAMC can improve mitochondrial function, reduce inflammation, and promote overall wellness. With its proven safety profile and broad applications, LAMC is a valuable tool in integrative medicine and IV infusion drip therapies.